Literature DB >> 31559648

Minding the gap: The impact of B-cell tolerance on the microbial antibody repertoire.

Joel Finney1, Akiko Watanabe1, Garnett Kelsoe1,2, Masayuki Kuraoka1.   

Abstract

B lymphocytes must respond to vast numbers of foreign antigens, including those of microbial pathogens. To do so, developing B cells use combinatorial joining of V-, D-, and J-gene segments to generate an extraordinarily diverse repertoire of B-cell antigen receptors (BCRs). Unsurprisingly, a large fraction of this initial BCR repertoire reacts to self-antigens, and these "forbidden" B cells are culled by immunological tolerance from mature B-cell populations. While culling of autoreactive BCRs mitigates the risk of autoimmunity, it also opens gaps in the BCR repertoire, which are exploited by pathogens that mimic the forbidden self-epitopes. Consequently, immunological tolerance, necessary for averting autoimmune disease, also acts to limit effective microbial immunity. In this brief review, we recount the evidence for the linkage of tolerance and impaired microbial immunity, consider the implications of this linkage for vaccine development, and discuss modulating tolerance as a potential strategy for strengthening humoral immune responses.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  BCR repertoire; humoral immunity; tolerance; vaccination

Mesh:

Substances:

Year:  2019        PMID: 31559648      PMCID: PMC6935408          DOI: 10.1111/imr.12805

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  156 in total

1.  HIV vaccine design and the neutralizing antibody problem.

Authors:  Dennis R Burton; Ronald C Desrosiers; Robert W Doms; Wayne C Koff; Peter D Kwong; John P Moore; Gary J Nabel; Joseph Sodroski; Ian A Wilson; Richard T Wyatt
Journal:  Nat Immunol       Date:  2004-03       Impact factor: 25.606

Review 2.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

3.  Elimination of germinal-center-derived self-reactive B cells is governed by the location and concentration of self-antigen.

Authors:  Tyani D Chan; Katherine Wood; Jana R Hermes; Danyal Butt; Christopher J Jolly; Antony Basten; Robert Brink
Journal:  Immunity       Date:  2012-11-08       Impact factor: 31.745

4.  Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls.

Authors:  Laurent Verkoczy; Yao Chen; Hilary Bouton-Verville; Jinsong Zhang; Marilyn Diaz; Jennifer Hutchinson; Ying-Bin Ouyang; S Munir Alam; T Matt Holl; Kwan-Ki Hwang; Garnett Kelsoe; Barton F Haynes
Journal:  J Immunol       Date:  2011-09-09       Impact factor: 5.422

5.  Induction of lupus autoantibodies by adjuvants.

Authors:  Minoru Satoh; Yoshiki Kuroda; Hideo Yoshida; Krista M Behney; Akiei Mizutani; Jun Akaogi; Dina C Nacionales; Thomas D Lorenson; Robert J Rosenbauer; Westley H Reeves
Journal:  J Autoimmun       Date:  2003-08       Impact factor: 7.094

Review 6.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

7.  Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site.

Authors:  Aaron G Schmidt; Khoi T Do; Kevin R McCarthy; Thomas B Kepler; Hua-Xin Liao; M Anthony Moody; Barton F Haynes; Stephen C Harrison
Journal:  Cell Rep       Date:  2015-12-17       Impact factor: 9.423

8.  BCR and Endosomal TLR Signals Synergize to Increase AID Expression and Establish Central B Cell Tolerance.

Authors:  Masayuki Kuraoka; Pilar B Snowden; Takuya Nojima; Laurent Verkoczy; Barton F Haynes; Daisuke Kitamura; Garnett Kelsoe
Journal:  Cell Rep       Date:  2017-02-14       Impact factor: 9.995

9.  Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.

Authors:  Sam Hoot; Andrew T McGuire; Kristen W Cohen; Roland K Strong; Lars Hangartner; Florian Klein; Ron Diskin; Johannes F Scheid; D Noah Sather; Dennis R Burton; Leonidas Stamatatos
Journal:  PLoS Pathog       Date:  2013-01-03       Impact factor: 6.823

10.  Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires.

Authors:  Kevin R McCarthy; Akiko Watanabe; Masayuki Kuraoka; Khoi T Do; Charles E McGee; Gregory D Sempowski; Thomas B Kepler; Aaron G Schmidt; Garnett Kelsoe; Stephen C Harrison
Journal:  Immunity       Date:  2018-01-16       Impact factor: 43.474

View more
  6 in total

Review 1.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

Review 2.  Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities.

Authors:  Céline M Laumont; Allyson C Banville; Mara Gilardi; Daniel P Hollern; Brad H Nelson
Journal:  Nat Rev Cancer       Date:  2022-04-07       Impact factor: 69.800

3.  Tracing Self-Reactive B Cells in Normal Mice.

Authors:  Takuya Nojima; Alexander E Reynolds; Daisuke Kitamura; Garnett Kelsoe; Masayuki Kuraoka
Journal:  J Immunol       Date:  2020-05-15       Impact factor: 5.422

Review 4.  Generation of High Quality Memory B Cells.

Authors:  Takeshi Inoue; Ryo Shinnakasu; Tomohiro Kurosaki
Journal:  Front Immunol       Date:  2022-01-12       Impact factor: 7.561

5.  Comprehending B-Cell Epitope Prediction to Develop Vaccines and Immunodiagnostics.

Authors:  Salvador Eugenio C Caoili
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

6.  Pathogen Moonlighting Proteins: From Ancestral Key Metabolic Enzymes to Virulence Factors.

Authors:  Luis Franco-Serrano; David Sánchez-Redondo; Araceli Nájar-García; Sergio Hernández; Isaac Amela; Josep Antoni Perez-Pons; Jaume Piñol; Angel Mozo-Villarias; Juan Cedano; Enrique Querol
Journal:  Microorganisms       Date:  2021-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.